MCA Stability Tool

Find stability recommendations for tablets and capsules.

Product Search

Stability Notes

Protect from light and moisture. Orodispersible tablets, therefore hygroscopic.

Provenance

Compatibility recommendation derived from Olanzapine 20mg orodispersible tablets sugar free (Accord Healthcare Ltd).

Stability Notes

Protect from light and moisture. Orodispersible tablets, therefore hygroscopic.

Provenance

Compatibility recommendation derived from Olanzapine 20mg orodispersible tablets sugar free (Accord Healthcare Ltd).

Stability Notes

Protect from light and moisture. Orodispersible tablets, therefore hygroscopic.

Provenance

Compatibility recommendation derived from Olanzapine 20mg orodispersible tablets sugar free (Accord Healthcare Ltd).

Stability Notes

Hygroscopic. Protect from light and moisture. Can cause contact dermatitis, wear gloves if handling tablets. May discolour. Max 28 days in MCA.

Provenance

Compatibility recommendation derived from Eli Lilly and Accord Pharmaceuticals Ltd products.

Stability Notes

Hygroscopic. Protect from light and moisture. Can cause contact dermatitis, wear gloves if handling tablets. May discolour. Max 28 days in MCA.

Provenance

Compatibility recommendation derived from Eli Lilly and Accord Pharmaceuticals Ltd products.

Stability Notes

Hygroscopic. Protect from light and moisture. Can cause contact dermatitis, wear gloves if handling tablets. May discolour. Max 28 days in MCA.

Provenance

Compatibility recommendation derived from Eli Lilly and Accord Pharmaceuticals Ltd products.

Stability Notes

Hygroscopic. Protect from light and moisture. Can cause contact dermatitis, wear gloves if handling tablets. May discolour. Max 28 days in MCA.

Provenance

Compatibility recommendation derived from Eli Lilly and Accord Pharmaceuticals Ltd products.

Stability Notes

Hygroscopic. Protect from light and moisture. Can cause contact dermatitis, wear gloves if handling tablets. May discolour. Max 28 days in MCA.

Provenance

Compatibility recommendation derived from Eli Lilly and Accord Pharmaceuticals Ltd products.

Stability Notes

Hygroscopic. Protect from light and moisture. Can cause contact dermatitis, wear gloves if handling tablets. May discolour. Max 28 days in MCA.

Provenance

Compatibility recommendation derived from Eli Lilly and Accord Pharmaceuticals Ltd products.

Stability Notes

Hygroscopic. Protect from light and moisture. Can cause contact dermatitis, wear gloves if handling tablets. May discolour. Max 28 days in MCA.

Provenance

Compatibility recommendation derived from Eli Lilly and Accord Pharmaceuticals Ltd products.

Stability Notes

Hygroscopic. Protect from light and moisture. Can cause contact dermatitis, wear gloves if handling tablets. May discolour. Max 28 days in MCA.

Provenance

Compatibility recommendation derived from Eli Lilly and Accord Pharmaceuticals Ltd products.

Stability Notes

Hygroscopic. Protect from light and moisture. Can cause contact dermatitis, wear gloves if handling tablets. May discolour. Max 28 days in MCA.

Provenance

Compatibility recommendation derived from Eli Lilly and Accord Pharmaceuticals Ltd products.

Stability Notes

Hygroscopic. Protect from light and moisture. Can cause contact dermatitis, wear gloves if handling tablets. May discolour. Max 28 days in MCA.

Provenance

Compatibility recommendation derived from Eli Lilly and Accord Pharmaceuticals Ltd products.

Stability Notes

Hygroscopic. Protect from light and moisture. Can cause contact dermatitis, wear gloves if handling tablets. May discolour. Max 28 days in MCA.

Provenance

Compatibility recommendation derived from Eli Lilly and Accord Pharmaceuticals Ltd products.

Stability Notes

Hygroscopic. Protect from light and moisture. Can cause contact dermatitis, wear gloves if handling tablets. May discolour. Max 28 days in MCA.

Provenance

Compatibility recommendation derived from Eli Lilly and Accord Pharmaceuticals Ltd products.

Print this list

Medicines under this category are suitable for use inside MCAs, although this is likely to be an off-label use.
Medicines under this category can theoretically be used inside an MCA; however, mitigations may need to be considered.
Medicines under this category are not suitable for use inside MCAs.
We do not have stability information for these medicines and therefore cannot make a recommendation on suitability in an MCA.